drugset / Trial / NCT01802515

A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment

NCT01802515

Terminated 14 enrolled Yale University
RandomizedParallel-groupDouble-blindTreatment

Summary

The main goal of this study is to evaluate the safety and tolerability of 40 or 80 mg atomoxetine as a treatment for cocaine dependence. The Phase I studies summarized above support the safety of atomoxetine in combination with stimulants. As the next step, the investigators will evaluate the safety and tolerability of atomoxetine in a small clinical trial with cocaine users. If atomoxetine is found to be promising in this study and sufficiently powered, double-blind, placebo-controlled studies will be proposed.

Timeline

Start
2012-12
Primary completion
2014-03
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atomoxetine Other / unclassified 40 mg Oral
Comparator Atomoxetine Other / unclassified 80 mg Oral